Fox Chase Research at the ASCO Annual Meeting

News & Publications

Press Releases, Social Media, Video
Press Kit Resources
Read more »

News Releases

Fox Chase’s Breast Cancer Treatment Program Earns Prestigious NAPBC Accreditation for the Third Time
(Aug 20, 2015)

The National Accreditation Program for Breast Cancers is administered by the American College of Physicians.

Fox Chase Cancer Center Top Docs Offer Free Skin Cancer Screenings at 2015 Miles for Melanoma Philadelphia
(Aug 11, 2015)

Sunday, August 16, 2015, 7-9 am. Individuals seeking a full body exam will be seen on the to ensure privacy; all other spot check examinations will be viewed within the tent. The Mobile Screening Unit, supported by the Flyers Wives Charities enables Fox Chase to reach communities throughout the Greater Philadelphia region.

Mutations that Predict Response to Therapy Could Guide Treatment of Bladder Cancer
(Aug 5, 2015)

The findings, released online August 1st in European Urology, suggest that defects in the ability to repair DNA damage represent an Achilles heel for tumors, making them more vulnerable to DNA-damaging drugs.

Press Releases 2015

Find a Clinical Trial

Find a Clinical Trial

Benefit from new cancer treatments
Read more »

Fox Chase Research Faculty - Alphabetical Listing

Faculty Directory

Our research faculty
Read more »

Each year, Fox Chase Cancer Center researchers present their findings at the annual meeting of the American Society of Clinical Oncology (ASCO). 

ASCO 2015

See what Fox Chase Cancer Center researchers are presenting at the 51st annual meeting of the American Society of Clinical Oncology (ASCO).

Pembrolizumab may be Promising Treatment for Urothelial Cancer
(Jun 1, 2015)
Researchers Developing New Targeted and Immune Therapies for Colorectal Cancer Molecular Subtypes
(May 27, 2015)
Patient interest, willingness to pay out of pocket costs for tumor genetic profiling assessed by Fox Chase researchers
(May 21, 2015)
Next Generation Sequencing-Based Tumor Genomic Profiling Aids in Detecting Hereditary Variants in Cancer Risk Genes
(May 20, 2015)
African Americans Prone To Display Negative Perceptions of Cancer-Related Clinical Trials
(May 19, 2015)
New Targeted Treatment IMMU-130 Shows Promise in Patients with Metastatic Colon Cancer
(May 18, 2015)


ASCO 2014

See what Fox Chase Cancer Center researchers are presenting at the 50th annual meeting of the American Society of Clinical Oncology (ASCO).

 

 

 

 

 


Fox Chase at ASCO 2013

Head and Neck Cancer Patients Fare Better with HPV
(May 29, 2013)
Fox Chase Researchers Uncover Novel Mechanism of Promising Drug Treatment for Colon Cancer
(May 29, 2013)
Many Solid Tumors Carry Genetic Changes Targeted by Existing Compounds
(May 29, 2013)
Fox Chase Study Shows that for Patients with Metastatic Pancreatic Cancer, Both Treatment and Survival Decrease with Advanced Age
(May 29, 2013)
New Technique Alleviates Painful Bone Metastases
(May 29, 2013)
Fox Chase Researchers Narrow the Search for Biomarkers of Drug Resistance in Head and Neck Cancer Patients
(May 29, 2013)
Researchers Investigate a Less Toxic Radiation Treatment for HPV-Positive Oropharynx Cancer
(May 29, 2013)
New Therapy is Tolerable in Lung Cancer
(May 29, 2013)

 .

Forward
Forward
broadening the conversation
about cancer

Online at 
forward.foxchase.org »

NOW
FOX CHASE NOW

Online at 
foxchase.org/ foxchasenow/ »


More Fox Chase Cancer Center Press Releases

News Contacts

Jeremy Moore
Senior Director, Communications
Jeremy.Moore@fccc.edu